Different kinetics of NT-proBNP and sST2 highlight different therapeutic pathways of sacubitril/valsartan

被引：0
|
作者：
Mattavelli, I.
Mapelli, M.
Salvioni, E.
Bonomi, A.
Palermo, P.
Banfi, C.
Paolillo, S.
Biondi, M. L.
Agostoni, P.
机构：
[1] Monzino Cardiol Ctr, Milan, Italy
[2] Federico II Univ Hosp, Naples, Italy
来源：
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING | 2023年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I17 / I19
页数：3
相关论文
共 50 条
  • [1] DIFFERENT KINETICS OF NT-PROBNP AND SST2 HIGHLIGHT DIFFERENT THERAPEUTIC PATHWAYS OF SACUBITRIL/VALSARTAN
    Mapelli, M.
    Mattavelli, I.
    Salvioni, E.
    Bonomi, A.
    Palermo, P.
    Banfi, C.
    Paolillo, S.
    Biondi, M.
    Agostoni, P.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [2] DIFFERENT KINETICS OF NT-PROBNP AND S-ST2 HIGHLIGHT DIFFERENT THERAPEUTIC THERAPEUTIC PATHWAYS OF SACUBITRIL/VALSARTAN
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Bonomi, Alice
    Palermo, Pietro
    Banfi, Cristina
    Paolillo, Stefania
    Biondi, Maria Luisa
    Agostoni, Piergiuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [3] Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
    Mapelli, Massimo
    Mattavelli, Irene
    Salvioni, Elisabetta
    Bonomi, Alice
    Capra, Nicolo
    Palermo, Pietro
    Banfi, Cristina
    Paolillo, Stefania
    Biondi, Maria Luisa
    Agostoni, Piergiuseppe
    DRUGS IN R&D, 2023, 23 (04) : 397 - 402
  • [4] Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
    Massimo Mapelli
    Irene Mattavelli
    Elisabetta Salvioni
    Alice Bonomi
    Nicolò Capra
    Pietro Palermo
    Cristina Banfi
    Stefania Paolillo
    Maria Luisa Biondi
    Piergiuseppe Agostoni
    Drugs in R&D, 2023, 23 : 397 - 402
  • [5] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
    Wei Pan
    Donghui Yang
    Peng Yu
    Huizhen Yu
    BMC Cardiovascular Disorders, 20
  • [6] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
    Pan, Wei
    Yang, Donghui
    Yu, Peng
    Yu, Huizhen
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [7] Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
    Takigami, Y.
    Ishii, S.
    Iida, Y.
    Ikeda, Y.
    Nabeta, T.
    Ako, J.
    Nasu, T.
    Kanaoka, K.
    Kagiyama, N.
    Kida, K.
    Fujimoto, W.
    Kikuchi, A.
    Ijichi, T.
    Shibata, T.
    Matsumoto, S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [8] sST2、BNP、NT-proBNP对HF患者鉴别诊断意义
    张国梁
    陈还珍
    常念欢
    耿小红
    李梅英
    世界最新医学信息文摘, 2016, 16 (11) : 2 - 3
  • [9] Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment
    Goena, C.
    Escolar, V.
    Laskibar, A.
    Gomez, C.
    Natividad, R.
    Romero, A.
    Perez De Nanclares, M.
    Rilo, I.
    Quintas, L.
    Solla, I.
    Zugazabeitia, G.
    Gil, P.
    Rodriguez, I.
    Urreta, I.
    Lozano, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 138 - 138
  • [10] Sacubitril/valsartan in HFrEF patients with low NT-proBNP levels: any benefit?
    Pereira, S. Sara Couto
    Agostinho, J. R.
    Rodrigues, T.
    Antonio, P. Silverio
    Morais, P. Simoes
    Cunha, N.
    Da Silva, P. Alves
    Brito, J.
    Silva, B.
    Santos, R.
    Rigueira, J.
    Nunes-Ferreira, A.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 133 - 133
12345